Navigation Links
New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
Date:12/10/2008

ves of women with advanced breast cancer.

"Researching new cancer treatments is a complex step by step process. Each success helps lay the foundation for the next step forward," said William M. Burns, CEO Division Roche Pharmaceuticals. "These results show that we are making significant progress towards giving doctors and their breast cancer

patients better and more effective treatment options to fight this devastating disease at all stages," he added.

    Presentation of Data

    Herceptin

    Gianni L et al  Neoadjuvant trastuzumab in patients with   Friday 12th,
                    HER2-positive locally advanced breast      December
                    cancer: primary efficacy analysis of the   09:30 hrs
                    NOAH trial                                 General
                                                               Session 3
                                                               (Hall D)

    Xeloda

    Joensuu H et    Significant improvement in                 Sunday 14th,
    al. for The     recurrence-free survival (RFS)             December
    Finnish Breast  when capecitabine (X) is                   11:45 hrs
    Cancer Group    integrated into docetaxel (T)              General
                    5-FU + epirubicin + cyclophosphamide       Session 7
                    (CEF) adjuvant therapy for high-risk
                    early breast cancer (BC): interim
                    analysis of the FinXX-trial.

    Avastin

    Smith IE et al  Primary analysis of study MO19391, an      Saturday
                    open-label safety study of bevacizumab     13th,
                    plus taxane-based therapy as 1st-line      December
                    treatment of patients with locally         07:00 hrs
                    recurrent or metastatic breast cancer.     Poster
                                                               Session 4

'/>"/>
SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
5. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
6. Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer
7. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
10. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
11. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014  BioSpecifics Technologies Corp. (NASDAQ: BSTC ), ... as XIAFLEX ® in the U.S. and XIAPEX ® ... Tom Wegman , will present at the following upcoming investor ... & Renshaw 16 th Annual Global Investment ... September 9, 2014 at 9:10 a.m. EDT , ...
(Date:9/2/2014)... SAN DIEGO , Sept. 2, 2014 /PRNewswire/ ... an oncology company focused on the clinical development ... it has completed enrollment in a randomized Phase ... candidate Pracinostat in combination with azacitidine in patients ... (MDS). The multi-center, placebo-controlled, double-blind study enrolled a ...
(Date:9/2/2014)... ANTONIO , Sept. 2, 2014 ... medical technology company focused on innovating lifesaving devices ... the appointment of Dr. Gabriele Niederauer , ... and CEO. Following the recent closure of Series ... Mark for the Surfacer™ Inside-Out Access Catheter System, ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 2MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 3MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 4Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO 2
... THOUSAND OAKS, Calif., Sept. 24 Amgen (Nasdaq: ... EPOGEN® and PROCRIT® (Epoetin alfa) vials are being voluntarily ... as a precaution.  The product that is being recalled ... barely visible in most cases. The lamellae result from ...
... Pharmasset, Inc. (Nasdaq: VRUS ) announces that management ... September 27-28, 2010 at the New York Palace Hotel, New ... will provide an overview of the company at the JMP ... To access a simultaneous webcast of Mr. Price,s ...
Cached Medicine Technology:Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 2Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 3Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 4Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 5Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 6Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 7Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 8Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 9Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 10Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 11Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 12Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 13Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 14Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 15Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 16Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 17Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 18Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 19Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 20Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 21Pharmasset to Present at the JMP Healthcare Conference 2Pharmasset to Present at the JMP Healthcare Conference 3
(Date:9/2/2014)... Two Kansas State University biochemists have discovered a ... for Staphylococcus aureus , a pathogenic bacterium that ... year. , Brian Geisbrecht, professor of biochemistry and molecular ... S. aureus , which is the cause of ... scientific journal Proceedings of the National Academy of ...
(Date:9/2/2014)... Vertebral invasive compression fractures called spine fractures, ... our spine suffers crack or gets deformed. Vertebral compression ... with osteoporosis or low bone density. Though osteoporosis is ... metastatic tumors and extensive trauma such as an accident, ... lead to such fractures. , The placement of such ...
(Date:9/2/2014)... 02, 2014 HMP Communications Holdings ... is proud to announce the acquisition of Nutrition411.com ... designed for healthcare professionals who integrate diet and nutrition ... access to:, , Late-breaking news related ... topic centers for diabetes, oncology, renal disease, wound care, ...
(Date:9/2/2014)... As an industry transformation expert, it was ... predict change. Fortunately for him, that valuable skill has stuck ... that are eager for change — such as the hearing ... market indicated it was ripe for better customer service, better ... a result, he took matters into his own hands and ...
(Date:9/2/2014)... New research involving mice suggests that the key to ... medicine cabinet. In a report published in the ... that macrophages from the lungs of old mice had ... from young mice, but these changes were reversed by ... consequences on immune function," said Joanne Turner, Ph.D., a ...
Breaking Medicine News(10 mins):Health News:Biochemists find new treatment options for staph infections, inflammatory diseases 2Health News:An Overview of the Minimally Invasive Vertebral Compression Fracture Repair Market by Transparency Market Research 2Health News:An Overview of the Minimally Invasive Vertebral Compression Fracture Repair Market by Transparency Market Research 3Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2Health News:David Sapio Launches Zounds Hearing Franchise 2
... Vitamin D, but be Careful Not to Burn Cautions Tanning ... Indoor Tanning Association (ITA) is encouraging beach goers to tan ... good health, overexposure to UV light can be a dangerous ... order for tanners to get all the benefits of UV ...
... 16 , WHO: Nancy Floyd Haworth Foundation (Breast cancer Education and, ... 18th annual Breast Cancer Luncheon and 3 FREE Educational Seminars, WHEN: Saturday, ... 9:00 AM--12 Noon: 3 FREE ... choose two you wish to attend. Call (505) 265-6343 to reserve your seat.) ...
... Nuclear Cardiology and Cardiac CT, is taking place in ... the ESC Working Group on Nuclear Cardiology and Cardiac ... and the American Society of Nuclear Cardiology (ASNC), now ... Nuclear Cardiology and Cardiac CT through practice, education and ...
... high-density genome wide analysis of participants in the Alzheimer,s ... complete and that data will be shared with scientists ... data will be used by researchers to search for ... which currently affects up to 5 million people in ...
... has workers looking over their shoulders according to ... of U.S. workers said their work atmosphere felt ... Tell It Now(SM) survey released by ComPsych today. ... "panicky." ComPsych Corporation is the world,s largest provider ...
... Physicians to E-Prescribing as First Step Toward Connected ... -- A new public/private partnership called PaperFree ... launched a plan to jump-start America,s electronic health ... 100 "electronic healthcare ambassadors" with a goal to ...
Cached Medicine News:Health News:Indoor Tanning Association Promotes Responsible Tanning for Spring Breakers 2Health News:Breast Cancer Awareness Event Including Free Educational Seminars 2Health News:Cardiac imaging highlighted at Biennial ICNC-9 2Health News:Cardiac imaging highlighted at Biennial ICNC-9 3Health News:Cardiac imaging highlighted at Biennial ICNC-9 4Health News:Alzheimer's Disease Neuroimaging Initiative announces completion of genome-wide analysis 2Health News:Alzheimer's Disease Neuroimaging Initiative announces completion of genome-wide analysis 3Health News:Work Atmosphere Is Worried, Panicky, Say Majority of U.S. Employees 2Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 2Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 3Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 4Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 5Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 6Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: